Cumberland Pharmaceuticals Inc.
CPIX
Get informed when a big investor buys or sells
+ FollowMarket Cap$100.09M
Close$
$12.17
61.2% upside
Current Fair Value
61.2% upsideUndervalued by 61.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $100.09 Million |
|---|---|
| Enterprise Value | $99.15 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.19 |
| Beta | 0.1 |
| Outstanding Shares | 14,960,210 |
Return
| Return on Equity | -33.42% |
|---|---|
| Return on Assets | -10.19% |
| Return on Invested Capital | -20.10% |
Valuation & Multiples
| P/E Ratio | -13.51 |
|---|---|
| PEG | 3.86 |
| Price to Sales | 3.78 |
| Price to Book Ratio | 7.55 |
| Enterprise Value to Revenue | 2.36 |
| Enterprise Value to EBIT | -13.51 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.47 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$8.50 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$8.57 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3869▼ 107.56% |
|---|---|
| Total Calls | 108,800▲ 270.07% |
| Total Puts | 42,100▼ 2.09% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 18.46%▼ 1.32% |
|---|---|
| Total Invested | $8.97M▼ 23.77% |
| Investors Holding | 34▲ 3.00% |
ESG Score
No data
About Cumberland Pharmaceuticals Inc.
90 employeesCumberland Emerging Technologies, Inc.(www.cet-fund.com)is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN and WinHealth Pharma. The mission of CET is to bring biomedical technologies and produ...